Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04222959 · ClinicalTrials.gov registry record · NA
An Intervention to Reduce Risk Factors for Adolescent Pregnancy
A NA study of Behavioral Changes, sponsored by San Diego State University.
- Completed
- Registry status
- NA
- Development phase
- 240
- Enrollment target
- 1
- Study location
NCT04222959: Completed NA study of Behavioral Changes, sponsored by San Diego State University.
NCT04222959 is a NA study of Behavioral Changes that has completed, run by San Diego State University. The registered enrollment target is 240 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04222959, a NA study of Behavioral Changes, has completed, sponsored by San Diego State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators will assess the preliminary effects of Girls Invest, an innovative savings intervention that aims to reduce economic, social, and health behavior risks associated with disproportionately high rates of pregnancy among US Latina adolescents. Girls Invest involves a multidisciplinary conceptual model adapting the most effective prevention strategies from the disciplines of public health and economics. Participants receive a savings account (via our collaborating bank) with $100 deposited in increments based on completion of each module of a gender and life skills training via a mobile "app."
Primary Outcome
Contraceptive use: Condom use and other contraception use and consistency of use.
Conditions Studied
Interventions
- BEHAVIORAL Girls Invest Intervention
Study Locations (1)
California
- San Diego State University - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2021-12-01 |
| Est. Completion | 2023-12-28 |
| Phase | NA |
What the finished NCT04222959 record still lists
NCT04222959 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Behavioral Changes appearing as the primary indexed condition, and to 1 intervention - of which Girls Invest Intervention is the first listed.
NCT04222959 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04222959 about?
NCT04222959 is a clinical study titled "An Intervention to Reduce Risk Factors for Adolescent Pregnancy". Investigators will assess the preliminary effects of Girls Invest, an innovative savings intervention that aims to reduce economic, social, and health behavior risks associated with disproportionately high rates of pregnancy among US Latina adolescents. Girls Invest involves a multidisciplinary conc...
What is the current status of trial NCT04222959?
This trial is currently completed. It is a NA study. The enrollment target is 240 participants. The study started on 2021-12-01. Estimated completion is 2023-12-28.
What conditions does trial NCT04222959 study?
This clinical trial studies the following conditions: Behavioral Changes.
What interventions are being tested in trial NCT04222959?
The interventions under investigation include: Girls Invest Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04222959?
This trial is sponsored by San Diego State University, which has 118 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04222959 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04222959's enrollment target sits among peer trials
240 440th of 2000 higher than 1,542 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI